Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire? P. C. ButlerA. V. MatveyenkoR. Elashoff Commentary Open access 06 November 2009 Pages: 1 - 6
The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation H. KolbT. Mandrup-Poulsen Review 05 November 2009 Pages: 10 - 20
Pancreatic duct replication is increased with obesity and type 2 diabetes in humans A. E. ButlerR. GalassoP. C. Butler Article Open access 21 October 2009 Pages: 21 - 26
Efficacy of leptin therapy in the different forms of human lipodystrophy A. Y. ChongB. C. LupsaP. Gorden Article 02 September 2009 Pages: 27 - 35
Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients E. VandemeulebrouckeB. KeymeulenThe Belgian Diabetes Registry Article 07 November 2009 Pages: 36 - 44
Telomere length predicts all-cause mortality in patients with type 1 diabetes A. S. AstrupL. TarnowH.-H. Parving Short Communication 04 October 2009 Pages: 45 - 48
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study E. RitzG. C. VibertiH. Haller Article Open access 30 October 2009 Pages: 49 - 57
A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus E. van den BergY. D. Reijmeron behalf of the Utrecht Diabetic Encephalopathy Study Group Article Open access 31 October 2009 Pages: 58 - 65
Short-form measures of diabetes-related emotional distress: the Problem Areas in Diabetes Scale (PAID)-5 and PAID-1 B. E. McGuireT. G. MorrisonF. J. Snoek Short Communication 20 October 2009 Pages: 66 - 69
Differential relationship between physical activity and progression to diabetes by glucose tolerance status: the Inter99 Study S. EngbergC. GlümerK. Borch-Johnsen Article 07 November 2009 Pages: 70 - 78
HOMA insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) study E. L. M. BarrA. J. CameronJ. E. Shaw Article 07 November 2009 Pages: 79 - 88
Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: findings from a prospective pregnancy cohort D. A. LawlorA. FraserS. M. Nelson Article 20 October 2009 Pages: 89 - 97
The interferon-induced helicase IFIH1 Ala946Thr polymorphism is associated with type 1 diabetes in both the high-incidence Finnish and the medium-incidence Hungarian populations A. JermendyI. SzatmáriThe HUNT1DGENES Programme Short Communication 20 October 2009 Pages: 98 - 102
Genetic association analysis of LARS2 with type 2 diabetes E. ReilingB. Jafar-MohammadiL. M. ’t Hart Article Open access 22 October 2009 Pages: 103 - 110
Relationship between fractional pancreatic beta cell area and fasting plasma glucose concentration in monkeys Y. SaishoA. E. ButlerP. C. Butler Article Open access 22 October 2009 Pages: 111 - 114
OVO homologue-like 1 (Ovol1) transcription factor: a novel target of neurogenin-3 in rodent pancreas A. VetereW.-C. LiA. Sharma Article 31 October 2009 Pages: 115 - 122
Regulation of wingless-type MMTV integration site family (WNT) signalling in pancreatic islets from wild-type and obese mice J. KrützfeldtM. Stoffel Article 08 November 2009 Pages: 123 - 127
Single pancreatic beta cells co-express multiple islet hormone genes in mice H. KatsutaT. AkashiG. C. Weir Article Open access 23 October 2009 Pages: 128 - 138
Effects of exenatide on circulating glucose, insulin, glucagon, cortisol and catecholamines in healthy volunteers during exercise E. Y. H. KhooJ. WallisP. Mansell Short Communication 07 November 2009 Pages: 139 - 143
An empirical index of insulin sensitivity from short IVGTT: validation against the minimal model and glucose clamp indices in patients with different clinical characteristics A. TuraS. SbrignadelloG. Pacini Article 30 October 2009 Pages: 144 - 152
Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas J. S. NachnaniD. G. BulchandaniL. M. Alba Article 13 September 2009 Pages: 153 - 159
Diabetes regulates mitochondrial biogenesis and fission in mouse neurons J. L. EdwardsA. QuattriniE. L. Feldman Article 22 October 2009 Pages: 160 - 169
Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-β in a murine diabetic model of atherosclerosis Y. PhamY. TuZ. Chai Article 22 October 2009 Pages: 170 - 179
Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes Y. F. DongL. LiuS. Kim-Mitsuyama Article 06 November 2009 Pages: 180 - 191
The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice A. M. D. WatsonJ. LiK. A. M. Jandeleit-Dahm Article 28 October 2009 Pages: 192 - 203
Diabetes treatment with insulin glargine and risk of malignancy: methodological pitfalls and ethical issues D. Simon Letter Open access 27 October 2009 Pages: 204 - 205
Insulin resistance and increased risk for malignant neoplasms: confounding of the data on insulin glargine J. M. NagelU. MansmannJ. Röhmel Letter 24 September 2009 Pages: 206 - 208
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues. Reply to Nagel JM, Mansmann U, Wegscheider K et al. [letter] and Simon D [letter] U. GrouvenL. G. HemkensP. T. Sawicki Letter 24 October 2009 Pages: 209 - 211
Dualities of interest are not restricted to financial ties to the pharmaceutical industry M. Nauck Letter 17 November 2009 Pages: 212 - 213
Duration of diabetes, glucose control and cardiovascular risk N. V. Emanuele Letter 20 October 2009 Pages: 214 - 215
Using individual patient data in meta-analyses of glucose-lowering studies J. S. YudkinB. Richter Letter 20 October 2009 Pages: 216 - 217
Intensive glucose control and macrovascular outcomes in type 2 diabetes. Reply to Emanuele NV [letter] and Yudkin JS, Richter B [letter] The CONTROL Group Letter 12 November 2009 Pages: 218 - 218
Erratum to: Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro S. K. PinnamaneniR. J. SouthgateM. J. Watt Erratum 29 October 2009 Pages: 219 - 219
